Medtronic (MDT) Total Non-Current Liabilities (2014 - 2026)
Medtronic's (MDT) quarterly Total Non-Current Liabilities came in at $40.5 billion in Q3 2026, down 1.39% year-over-year from $41.0 billion in Q3 2025, and down 1.09% quarter-over-quarter from $40.9 billion in Q2 2026.
Analysis
Medtronic (MDT) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends
Medtronic has disclosed Total Non-Current Liabilities across 13 years of filings, most recently posting $40.5 billion for Q3 2026.
- In Q3 2026, Total Non-Current Liabilities fell 1.39% year-over-year to $40.5 billion; the TTM figure through Jul 2026 stood at $40.5 billion (down 1.39% YoY), while the FY2026 annual figure was $40.9 billion, down 1.81% from the prior year.
- Total Non-Current Liabilities came in at $40.5 billion for Q3 2026 at Medtronic, down from $40.9 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $41.7 billion in Q2 2025 to a low of $36.2 billion in Q2 2022.
- Average Total Non-Current Liabilities over 5 years is $38.9 billion, with a median of $39.7 billion recorded in 2024.
- Year-over-year, Total Non-Current Liabilities fell 16.11% in 2022 and increased 10.48% in 2025.
- Over 5 years, Total Non-Current Liabilities stood at $40.8 billion in 2022, then retreated by 10.22% to $36.7 billion in 2023, then increased by 8.53% to $39.8 billion in 2024, then climbed by 2.34% to $40.7 billion in 2025, then retreated by 0.66% to $40.5 billion in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $40.5 billion in Q3 2026, $40.9 billion in Q2 2026, and $40.5 billion in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 178.50 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.21 Bn | 118.99 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 118.33 Bn | 109.51 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 104.21 Bn | 100.73 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 66.39 Bn | 65.86 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.69 Bn | 45.43 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 33.94 Bn | 32.48 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 21.15 Bn | 20.67 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Zimmer Biomet Holdings | 18.14 Bn | 17.73 Bn | 1.54 Bn | 9.53 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 40.46 Bn |
| Apr 24, 2026 | 40.90 Bn |
| Jan 23, 2026 | 40.52 Bn |
| Oct 24, 2025 | 40.73 Bn |
| Jul 25, 2025 | 41.03 Bn |
| Apr 25, 2025 | 41.66 Bn |
| Jan 24, 2025 | 38.83 Bn |
| Oct 25, 2024 | 39.79 Bn |
| Jul 26, 2024 | 39.67 Bn |
| Apr 26, 2024 | 37.70 Bn |
| Jan 26, 2024 | 37.02 Bn |
| Oct 27, 2023 | 36.66 Bn |
| Jul 28, 2023 | 37.00 Bn |
| Apr 28, 2023 | 36.92 Bn |
| Jan 27, 2023 | 40.21 Bn |
| Oct 28, 2022 | 40.84 Bn |
| Jul 29, 2022 | 36.88 Bn |
| Apr 29, 2022 | 36.17 Bn |
| Jan 28, 2022 | 36.98 Bn |
| Oct 29, 2021 | 39.33 Bn |